AFG
DGX icon

Allegheny Financial Group’s Quest Diagnostics DGX Stock Holding History

Allegheny Financial Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$341K Buy
1,609
+12
+0.8% +$2.35K 0.04% 215
2026
Q1 		$313K Hold
1,597
– – 0.04% 202
2025
Q4 		$277K Hold
1,597
– – 0.04% 210
2025
Q3 		$304K Hold
1,597
– – 0.06% 193
2025
Q2 		$287K Sell
1,597
-500
-24% -$86.8K 0.06% 189
2025
Q1 		$355K Buy
+2,097
New +$344K 0.09% 162

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Allegheny Financial Group's DGX Position: Q2 2026 in Review

Allegheny Financial Group increased its Quest Diagnostics (DGX) stake by 0.75% in Q2 2026, buying an estimated $2.35K and bringing the position to 1,609 shares worth $341K. The position accounts for 0.04% of the portfolio, ranked #215.

Allegheny Financial Group first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. The position peaked at $355K in Q1 2025. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Allegheny Financial Group held 1,609 shares of Quest Diagnostics worth $341K as of Q2 2026.
  • Allegheny Financial Group bought 12 Quest Diagnostics shares in Q2 2026, an estimated $2.35K.
  • Quest Diagnostics made up 0.04% of Allegheny Financial Group's portfolio in Q2 2026, its #215 holding.
  • Allegheny Financial Group first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • Allegheny Financial Group's Quest Diagnostics position peaked at $355K in Q1 2025.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.